| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_479a9a5f1ff07361195a70cf47aa768e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0079 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 |
| filingDate |
2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47fb80d8669a7a679532194719192e7 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021113730-A1 |
| titleOfInvention |
Methods, systems, and compositions for achieving a healthy intraocular pressure following combined glaucoma filtration surgery and cataract extraction |
| abstract |
Methods and systems for applying beta radiation to a treatment area, such as a target area of a bleb, in combination with combined glaucoma and cataract surgery. The methods and systems herein may help achieve and/or maintain a healthy intraocular pressure, maintain functioning blebs and/or drainage holes arising from glaucoma drainage procedures or surgeries, help avoid scar formation or wound reversion, inhibit or reduce fibrogenesis and/or inflammation in the blebs or surrounding areas, etc. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737920-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291585-B2 |
| priorityDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |